Self-monitoring of blood pressure to guide titration of antihypertensive medication-a new era in hypertension management?
- PMID: 30881886
- PMCID: PMC6382658
- DOI: 10.21037/cdt.2018.08.01
Self-monitoring of blood pressure to guide titration of antihypertensive medication-a new era in hypertension management?
Conflict of interest statement
Conflicts of Interest: MP Schlaich is supported by an NHMRC Research Fellowship and has received consulting fees, and/or travel and research support from Medtronic, Abbott, Novartis, Servier, Pfizer and Boehringer-Ingelheim. The other authors have no conflicts of interest to declare.
Comment on
-
Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial.Lancet. 2018 Mar 10;391(10124):949-959. doi: 10.1016/S0140-6736(18)30309-X. Epub 2018 Feb 27. Lancet. 2018. PMID: 29499873 Free PMC article. Clinical Trial.
References
-
- GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1345-422. 10.1016/S0140-6736(17)32366-8 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources